Examkin

Tüm alıştırma soruları

4736 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 1821Soru →

A 42-year-old woman comes to the clinic for a follow-up visit. One week ago, she was diagnosed with primary hypothyroidism and was started on levothyroxine 50 mcg daily. Today, she reports that her fatigue, dry skin, and cold intolerance have not improved. She asks if her medication dosage can be increased. She takes the medication every morning on an empty stomach with water. Vital signs are temperature 36.8°C (98.2°F), blood pressure 118/76 mmHg, pulse 68/min, and respirations 14/min. Physical examination reveals delayed relaxation of deep tendon reflexes but is otherwise unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Continue current management and measure thyroid-stimulating hormone in 5 weeks

Cevap

Continue current management and measure thyroid-stimulating hormone in 5 weeks
The most appropriate next step in management is to continue the current dosage and measure serum TSH in 5 weeks (making it 6 weeks total since initiation). Levothyroxine has a long half-life of approximately 7 days, meaning it takes about 4 to 6 weeks for serum TSH levels to reach a new steady state after initiating therapy or changing the dose. Therefore, monitoring TSH or adjusting the dose prior to this timeframe is not clinically useful. The patient's persistent symptoms are expected at this early stage, as full clinical improvement parallels the biochemical stabilization.

Adım Adım Çözüm

1
Analyze the patient's presentation and treatment timeline.
The patient is experiencing persistent hypothyroid symptoms only 1 week after initiating levothyroxine therapy.
Establishing the timeline of treatment is crucial for determining if the medication has had sufficient time to take effect.
2
Recall the pharmacokinetics and monitoring guidelines for levothyroxine.
Levothyroxine has a half-life of approximately 7 days, meaning it takes 4 to 6 weeks (about 4-5 half-lives) to reach a steady state in the blood.
Understanding the half-life prevents premature dose adjustments based on expected delayed responses.
3
Determine the appropriate next step in management.
The current dose should be maintained, and TSH should be re-evaluated at the 6-week mark (5 weeks from today) to accurately assess adequacy of the initial dose.
This avoids the risk of iatrogenic hyperthyroidism from prematurely escalating the dose before steady state is reached.

Anahtar Kavram

Patients initiated on levothyroxine for primary hypothyroidism should have their serum TSH checked no earlier than 4 to 6 weeks after starting therapy to allow for the achievement of a steady state.
Soru 1822Soru →

Following a high-speed motorcycle collision, a 26-year-old male rider is admitted directly to the trauma bay. He is profoundly agitated, clutching his chest, and struggling to breathe. Vital signs show a blood pressure of 70/35 mmHg, a heart rate of 142/min, a respiratory rate of 32/min, and an oxygen saturation of 82% despite receiving high-flow supplemental oxygen. Clinical evaluation demonstrates marked distension of the jugular veins, a rightward shift of the trachea, and a hyperresonant left hemithorax with completely absent breath sounds. What is the most appropriate immediate step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Immediate needle or finger thoracostomy

Cevap

Immediate needle or finger thoracostomy
The patient's presentation of severe respiratory distress, hypotension, jugular venous distension, tracheal deviation, and absent unilateral breath sounds is the classic clinical triad for a tension pneumothorax. This condition creates immense intrathoracic pressure that compresses the superior and inferior vena cava, drastically reducing venous return and causing obstructive shock. The correct immediate next step is rapid decompression of the affected pleural space via immediate needle or finger thoracostomy. This life-saving procedure converts the tension pneumothorax into a simple pneumothorax, immediately restoring cardiac output. It must be performed based solely on clinical suspicion before any radiographic confirmation.

Adım Adım Çözüm

1
Analyze the patient's vital signs and physical examination findings.
The patient exhibits severe hypotension, tachycardia, hypoxia, jugular venous distension, tracheal deviation, and unilateral absent breath sounds with hyperresonance.
Identifying these classic signs is essential to quickly diagnose obstructive shock secondary to a tension pneumothorax.
2
Determine the pathophysiology of the condition.
Air accumulation in the pleural space is compressing the mediastinum, severely impairing venous return to the heart and causing cardiovascular collapse.
Understanding the obstructive nature of the shock dictates that mechanical relief is the only effective primary treatment.
3
Select the most appropriate immediate intervention.
Needle or finger thoracostomy is identified as the required next step.
Immediate decompression must be performed before any diagnostic imaging or positive pressure ventilation to prevent imminent death.

Anahtar Kavram

Tension pneumothorax is a clinical diagnosis requiring immediate needle or finger thoracostomy to relieve obstructive shock prior to any diagnostic imaging.
Soru 1823Soru →

A 5252-year-old man presents to the clinic with acute, severe pain and swelling in his right knee that began 1212 hours ago. He reports the pain is so intense that he cannot tolerate the weight of his clothing over the joint. His medical history is significant for a deceased-donor renal transplant 44 years ago for end-stage renal disease secondary to hypertensive nephrosclerosis. His current medications include cyclosporine, mycophenolate mofetil, prednisone (5 mg5\text{ mg} daily), and amlodipine. Temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 132/84 mmHg132/84\text{ mmHg}, and pulse is 88/min88\text{/min}. Physical examination shows an erythematous, warm, and swollen right knee with exquisitely limited range of motion. Joint aspiration yields cloudy yellow fluid with a leukocyte count of 45,000/mm345,000\text{/mm}^3 (85%85\% neutrophils). Polarized light microscopy reveals negatively birefringent, needle-shaped crystals. Gram stain of the synovial fluid shows no organisms. Serum creatinine is 1.6 mg/dL1.6\text{ mg/dL}, which is at his baseline. Which of the following is the most appropriate initial pharmacologic intervention for this patient's acute joint condition?

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone injection

Cevap

Intra-articular triamcinolone injection is the most appropriate initial pharmacologic intervention for this patient.
The patient is experiencing an acute attack of monoarticular gout, confirmed by the pathognomonic finding of negatively birefringent, needle-shaped monosodium urate crystals. In a renal transplant recipient taking a calcineurin inhibitor (such as cyclosporine) who also has baseline renal impairment, standard systemic treatments for gout carry significant morbidity. Intra-articular glucocorticoid injections provide localized, rapid relief of monoarticular flares. This approach minimizes systemic absorption, completely avoiding dangerous drug-drug interactions and eliminating the risk of iatrogenic nephrotoxicity or allograft dysfunction.

Adım Adım Çözüm

1
Analyze the synovial fluid results.
The presence of negatively birefringent, needle-shaped crystals with a leukocyte count of 45,000/mm345,000\text{/mm}^3 and negative Gram stain confirms an acute monoarticular gout flare.
Accurate diagnosis is required before selecting pharmacotherapy, differentiating severe inflammation from active infection.
2
Evaluate the patient's comorbidities and current medication list.
The patient is a renal transplant recipient taking cyclosporine with baseline renal impairment (creatinine 1.6 mg/dL1.6\text{ mg/dL}).
Systemic gout medications have severe toxicities and interactions in solid organ transplant patients.
3
Identify contraindications to standard systemic gout therapies.
NSAIDs are nephrotoxic (especially with calcineurin inhibitors), and colchicine has a potentially fatal CYP3A4/P-glycoprotein interaction with cyclosporine.
Recognizing these interactions prevents iatrogenic allograft failure or systemic toxicity.
4
Select the optimal localized therapy.
Intra-articular glucocorticoids (e.g., triamcinolone) bypass systemic absorption and avoid drug interactions.
It provides rapid, targeted relief for a single affected joint without compromising the renal allograft.

Anahtar Kavram

Management of acute gout in renal transplant patients requires avoiding systemic NSAIDs (due to nephrotoxicity) and colchicine (due to severe CYP3A4/P-glycoprotein interactions with calcineurin inhibitors) by utilizing targeted intra-articular glucocorticoids for monoarticular flares.
Soru 1824Soru →

A 45-year-old man is evaluated in the emergency department for right-sided pleuritic chest pain and mild shortness of breath that began 12 hours ago. He has no past medical history. He works as a software engineer and lives with his wife. Vital signs are temperature 37.1°C (98.8°F), blood pressure 132/84 mmHg, heart rate 88/min, and respiratory rate 16/min. Pulse oximetry is 98% on room air. Physical examination reveals clear lungs, normal heart sounds, and mild swelling in the right calf. Laboratory testing shows a normal basic metabolic panel, and undetectable serum troponin I and brain natriuretic peptide (BNP). A CT pulmonary angiogram confirms a right lower lobe segmental pulmonary embolism. Bedside echocardiography demonstrates a normal-sized right ventricle with preserved systolic function. The patient's pain is well controlled. He is highly health literate and demonstrates clear understanding of his diagnosis and necessary precautions. Which of the following is the most appropriate care setting transition and disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home with a prescription for a direct oral anticoagulant and close outpatient follow-up

Cevap

The correct approach is to discharge the patient home with a prescription for a direct oral anticoagulant and arrange for close outpatient follow-up.
This patient presents with an acute pulmonary embolism but meets all established criteria for safe outpatient management. He is hemodynamically stable, has no evidence of right ventricular dysfunction (demonstrated by a normal echocardiogram and negative biomarkers), and lacks any significant comorbidities. His simplified Pulmonary Embolism Severity Index (sPESI) score is exactly 0 (criteria include: age < 80, no history of cancer, no chronic cardiopulmonary disease, heart rate < 110/min, systolic blood pressure ≥ 100 mmHg, and arterial oxygen saturation ≥ 90%). Furthermore, his psychosocial profile is highly favorable: he has excellent social support at home, intact health literacy, and well-controlled pain. In such low-risk scenarios, modern clinical guidelines strongly recommend direct discharge from the emergency department with a direct oral anticoagulant (e.g., apixaban or rivaroxaban) rather than inpatient admission.

Adım Adım Çözüm

1
Assess the patient's clinical stability and risk stratification scores.
The patient is hemodynamically stable, has a normal right ventricle on echocardiogram, negative cardiac biomarkers, and a simplified Pulmonary Embolism Severity Index (sPESI) score of 0.
Risk stratification objectively determines the need for inpatient versus outpatient management in acute pulmonary embolism.
2
Evaluate the patient's psychosocial context and functional capacity.
The patient is independent, highly health literate, has excellent home social support, and his pain is well controlled.
Safe outpatient management requires reliable patients who can adhere to anticoagulant treatment and recognize warning signs of deterioration.
3
Determine the optimal care setting based on the synthesis of clinical and social factors.
Immediate discharge to the home setting with oral anticoagulation is selected.
Current clinical guidelines strongly recommend outpatient management for carefully selected, low-risk patients to minimize healthcare-associated complications and optimize hospital bed utilization.

Anahtar Kavram

Low-risk acute pulmonary embolism (sPESI score of 0) in hemodynamically stable patients with good social support should be managed in the outpatient setting with direct oral anticoagulants.
Soru 1825Soru →

A 24-year-old pregnant woman presents to the obstetric clinic for her initial prenatal visit at 16 weeks of gestation. She feels well and has no active complaints. Physical examination shows normal vital signs, a gravid uterus appropriate for gestational age, and no mucosal lesions, chancre, or skin rashes. Prenatal screening laboratories show a reactive rapid plasma reagin (RPR) test with a titer of 1:64. Confirmatory testing with Treponema pallidum particle agglutination (TP-PA) is positive. The patient's electronic medical record indicates a history of severe anaphylaxis to amoxicillin during childhood, which was documented with an intensive care unit admission for airway compromise. Which of the following is the most appropriate pharmacologic management for this patient's infection?

Cevabı ve açıklamayı göster

Cevap: Admit for penicillin desensitization followed by intramuscular penicillin G benzathine

Cevap

Admit for penicillin desensitization followed by intramuscular penicillin G benzathine.
The correct intervention is to admit the patient for penicillin desensitization followed by administration of intramuscular penicillin G benzathine. Penicillin G is the only recognized and effective treatment to prevent maternal-fetal transmission of Treponema pallidum and treat fetal infection. For pregnant patients who have a confirmed or highly suspected IgE-mediated severe allergy to penicillin (such as anaphylaxis), the standard of care is not to use alternative antibiotics, but rather to perform penicillin desensitization in a monitored clinical setting, followed immediately by standard penicillin therapy.

Adım Adım Çözüm

1
Interpret the clinical and laboratory findings.
The patient has asymptomatic latent syphilis, confirmed by positive non-treponemal (RPR) and treponemal (TP-PA) tests.
Accurate diagnosis is required to initiate treatment that protects both the mother and the fetus from congenital syphilis.
2
Determine the standard of care for the diagnosed infection in a pregnant patient.
Penicillin G benzathine is the only recommended medication because it effectively crosses the placenta to treat fetal infection.
Alternative therapies used in non-pregnant adults are either teratogenic or fail to achieve adequate fetal tissue levels.
3
Address the patient's severe penicillin allergy.
The patient must undergo inpatient penicillin desensitization prior to receiving the curative penicillin G dose.
A history of anaphylaxis is an absolute contraindication to standard penicillin administration, but because alternatives are inadequate for congenital syphilis prevention, desensitization is strictly required.

Anahtar Kavram

Pregnant patients with syphilis and a severe penicillin allergy must undergo penicillin desensitization to receive penicillin G, as it is the only effective therapy for preventing congenital syphilis.
Soru 1826Soru →

A 45-year-old man presents to the emergency department with a 2-hour history of sudden-onset, severe, and diffuse abdominal pain. He has a history of chronic lower back pain managed with high-dose daily ibuprofen. He is in severe distress and lies completely still on the examination table. His temperature is 38.2°C (100.8°F), blood pressure is 92/58 mm Hg, pulse is 122/min, and respirations are 24/min. Abdominal examination demonstrates diffuse rigidity, involuntary guarding, and severe rebound tenderness. An upright chest radiograph reveals free air under the right hemidiaphragm. Which of the following are the most appropriate immediate steps in the management of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Administration of intravenous crystalloid fluids and broad-spectrum antibiotics; Urgent surgical consultation for exploratory laparotomy

Cevap

The correct steps are the administration of intravenous crystalloid fluids and broad-spectrum antibiotics, and an urgent surgical consultation for an exploratory laparotomy.
This patient presents with classic signs of a perforated hollow viscus, likely a peptic ulcer given his chronic NSAID use. The diagnosis is definitively established by the presence of a rigid, board-like abdomen and an upright chest radiograph demonstrating pneumoperitoneum (free air under the diaphragm). In the setting of an acute surgical abdomen with hemodynamic instability (tachycardia, hypotension, fever), the mandatory next steps are immediate medical stabilization with intravenous crystalloids and broad-spectrum antibiotics, followed immediately by an urgent surgical consultation for an exploratory laparotomy. Source control of the contamination is paramount to survival.

Adım Adım Çözüm

1
Analyze the clinical presentation and imaging findings.
The patient has a history of NSAID use, sudden severe abdominal pain, peritonitis (rigidity, guarding), and pneumoperitoneum (free air under the diaphragm) on x-ray.
Identifying these signs confirms the diagnosis of a perforated hollow viscus, likely a perforated peptic ulcer.
2
Assess the patient's hemodynamic status.
The patient is tachycardic, hypotensive, and febrile.
These vital signs indicate early septic shock secondary to intra-abdominal contamination.
3
Determine the necessary immediate medical and procedural interventions.
Immediate fluid resuscitation, broad-spectrum antibiotics, and urgent laparotomy are indicated.
Medical stabilization must occur concurrently with urgent surgical source control to prevent mortality.

Anahtar Kavram

Patients presenting with a perforated hollow viscus and peritonitis require immediate medical stabilization (IV fluids and broad-spectrum antibiotics) and concurrent emergent surgical repair (exploratory laparotomy); further diagnostic imaging or endoscopic procedures are strictly contraindicated.
Soru 1827Soru →

A 6666-year-old man comes to the clinic for evaluation of a chronic cough and blood-tinged sputum over the past three months. He reports a 55-kg (1111-lb) unintentional weight loss during this period. The patient has a 4545-pack-year smoking history and chronic obstructive pulmonary disease. Vital signs are within normal limits. Physical examination reveals decreased breath sounds at the right lung apex. Routine laboratory testing shows a serum calcium level of 10.810.8 mg/dL (reference: 8.4−10.28.4 - 10.2 mg/dL). A contrast-enhanced CT scan of the chest and upper abdomen reveals a 4.54.5-cm spiculated mass in the right upper lobe and a single enlarged right paratracheal lymph node measuring 1.81.8 cm. The liver and adrenal glands appear normal. Which of the following is the most appropriate next step in the diagnostic sequence?

Cevabı ve açıklamayı göster

Cevap: Whole-body positron emission tomography/computed tomography (PET/CT)

Cevap

Whole-body positron emission tomography/computed tomography (PET/CT)
In a patient with a high clinical and radiographic suspicion for stage I-III non-small cell lung cancer, the most appropriate next step before acquiring tissue is functional imaging with a whole-body PET/CT scan. PET/CT evaluates for occult regional nodal involvement and distant metastases. Detecting a distant metastasis changes the management algorithm entirely; the preferred biopsy site shifts to the metastatic lesion to simultaneously confirm the histologic diagnosis and establish stage IV disease, thereby sparing the patient from unnecessary surgical resections or multiple invasive procedures.

Adım Adım Çözüm

1
Analyze the clinical presentation and initial imaging.
The patient has a highly suspicious lung mass with regional lymphadenopathy, classic for non-small cell lung cancer (NSCLC).
Establishing the pre-test probability of malignancy dictates the aggressiveness and pathway of the subsequent diagnostic workup.
2
Determine the optimal sequencing of diagnosis and staging.
Systemic non-invasive functional imaging (PET/CT) must precede invasive tissue sampling.
The location of a biopsy must confirm both the histologic diagnosis AND the highest possible stage. PET/CT guides the clinician to the highest-yield biopsy site.
3
Evaluate the distractors against the principle of minimizing redundant invasive procedures.
Biopsying the primary lung mass or the regional node prematurely risks missing an occult distant metastasis, which would eventually require a second biopsy of the distant site to prove stage IV disease.
Performing invasive confirmatory tests before comprehensive non-invasive screening represents an error in diagnostic sequencing.

Anahtar Kavram

In patients with suspected lung cancer based on initial CT chest imaging, whole-body PET/CT should be performed before invasive tissue biopsy to identify distant metastases and determine the most appropriate (highest-stage) biopsy target.
Tahmini Süre:1m 30s
Soru 1828Soru →

A 62-year-old woman is evaluated in the intensive care unit regarding her anticoagulation management. Seven days ago, she was admitted for a massive pulmonary embolism and was initially started on a continuous unfractionated heparin infusion. Three days into her admission, her platelet count dropped from 240,000/mm³ to 85,000/mm³. A serotonin release assay was positive, confirming heparin-induced thrombocytopenia (HIT). Heparin was immediately discontinued, and a continuous intravenous argatroban infusion was initiated.

Over the past four days, her clinical condition has stabilized, and her platelet count has recovered to 165,000/mm³. The medical team decided to transition her to oral warfarin for long-term outpatient anticoagulation, and daily warfarin therapy was initiated. Today (day 4 of combined argatroban and warfarin therapy), her vital signs are stable. Laboratory results are as follows:

Laboratory ParameterResultReference Range
Platelet count175,000/mm³150,000-400,000/mm³
Activated partial thromboplastin time (aPTT)68 seconds25-35 seconds (Target: 60-80 seconds)
International normalized ratio (INR)2.40.8-1.2

Which of the following is the most appropriate next step in the monitoring and management of this patient's anticoagulation?

Cevabı ve açıklamayı göster

Cevap: Continue both argatroban and warfarin until the INR is at least 4.0

Cevap

Continue both argatroban and warfarin until the INR is at least 4.0
The correct answer is to continue both argatroban and warfarin until the INR is at least 4.0. Argatroban is a direct thrombin inhibitor used to treat heparin-induced thrombocytopenia (HIT). When transitioning from argatroban to warfarin for long-term outpatient management, a critical laboratory interaction must be monitored. Argatroban artifactually prolongs the prothrombin time (PT) and the corresponding international normalized ratio (INR). Consequently, if a patient is receiving both argatroban and warfarin, the measured INR is the sum of both the true warfarin effect and the argatroban artifact. Standard protocol dictates that warfarin and argatroban should be overlapped until the measured, combined INR is >4.0. Once this threshold is reached, argatroban is temporarily halted, and the INR is rechecked 4-6 hours later (after argatroban has cleared) to confirm that the true warfarin-induced INR is within the therapeutic range of 2.0-3.0. Discontinuing argatroban at a combined INR of 2.4 would inevitably result in a subtherapeutic true INR, exposing the patient to a high risk of recurrent thrombosis.

Adım Adım Çözüm

1
Identify the patient's current clinical phase and pharmacological regimen.
The patient is recovering from heparin-induced thrombocytopenia (HIT) and is currently being bridged from intravenous argatroban to oral warfarin.
Understanding the specific drugs involved is critical due to unique pharmacokinetic and assay interactions.
2
Evaluate the current laboratory parameters.
The platelet count has recovered to >150,000/mm³ (allowing for safe warfarin use), the aPTT is therapeutic for argatroban, and the INR is 2.4.
Lab values dictate the next sequence in therapeutic de-escalation.
3
Analyze the effect of the specific direct thrombin inhibitor on coagulation assays.
Argatroban directly inhibits thrombin in the laboratory assay, causing a false, significant elevation of the prothrombin time (PT) and INR.
This assay interference means the measured INR is not an accurate reflection of the warfarin effect alone.
4
Determine the appropriate monitoring protocol for this transition.
The guidelines mandate continuing both agents until the combined, measured INR is >4.0. Only then should argatroban be stopped, with a repeat INR drawn 4-6 hours later to ensure the true INR remains in the 2.0-3.0 therapeutic range.
Stopping argatroban at a combined INR of 2.4 would result in subtherapeutic anticoagulation and high risk of recurrent thrombosis.

Anahtar Kavram

When transitioning a patient from argatroban to warfarin, the argatroban falsely elevates the INR; therefore, both agents must be continued until the combined INR is >4.0 before stopping the argatroban.
Tahmini Süre:1m 30s
Soru 1829Soru →

A 64-year-old man is currently receiving treatment in the intensive care unit for a severe exacerbation of cystic fibrosis-related bronchiectasis. Twenty minutes ago, he experienced an episode of massive hemoptysis, expectorating approximately 500 mL of bright red blood. He was immediately intubated with an 8.0-mm single-lumen endotracheal tube to secure the airway. A bedside flexible bronchoscopy performed through the endotracheal tube reveals continuous, high-volume arterial bleeding originating from the right lower lobe bronchus. Despite targeted application of cold saline and epinephrine, the bleeding remains uncontrolled and is now rapidly flooding the trachea and spilling into the left mainstem bronchus. The patient's oxygen saturation has declined from 96% to 82% despite mechanical ventilation with a fraction of inspired oxygen of 1.0. Blood pressure is 112/74 mmHg and heart rate is 118/min. Which of the following is the most appropriate immediate next step in management?

Cevabı ve açıklamayı göster

Cevap: Advance the endotracheal tube into the left mainstem bronchus

Cevap

Advance the endotracheal tube into the left mainstem bronchus
Advancing the existing endotracheal tube into the left mainstem bronchus effectively isolates the bleeding right lung. This immediately halts the spillage of blood into the healthy left lung, allowing for effective single-lung ventilation and restoration of oxygenation. This rapid bedside maneuver stabilizes the patient, bridging them safely to definitive therapies like bronchial artery embolization, while avoiding the catastrophic risk of losing the airway during an attempted tube exchange in a blood-filled field.

Adım Adım Çözüm

1
Identify the primary mechanism of death in massive hemoptysis.
Patients with massive hemoptysis primarily die from asphyxiation due to blood flooding the healthy alveoli, not from hemorrhagic shock.
Recognizing asphyxiation as the immediate threat shifts the management focus entirely to airway isolation rather than fluid resuscitation or definitive hemostasis.
2
Evaluate the patient's current clinical status and existing interventions.
The patient is profoundly hypoxemic (SpO2 82% on 100% O2) because blood from the right lung is actively spilling into the left lung. He already has an 8.0-mm single-lumen endotracheal tube in place.
The existing endotracheal tube is securing the trachea but is not isolating the two lungs from each other.
3
Determine the safest and most rapid procedural method to achieve lung isolation.
Advancing the existing single-lumen endotracheal tube into the left mainstem bronchus is selected.
This maneuver instantly protects the healthy left lung and allows for oxygenation. Attempting to exchange the tube for a double-lumen tube in an airway full of blood carries a near-certain risk of airway loss and death.

Anahtar Kavram

In the management of massive hemoptysis, the immediate priority is protecting the non-bleeding lung to prevent asphyxiation; advancing an existing single-lumen endotracheal tube into the unaffected mainstem bronchus is the most rapid and safest emergency lung isolation procedure.
Soru 1830Soru →

A 65-year-old man is evaluated for sudden-onset, excruciating pain in his right lower extremity. He is currently on hospital day 7 following a mechanical mitral valve replacement. His daily medications include warfarin and a continuous unfractionated heparin infusion for bridging therapy until his international normalized ratio (INR) is therapeutic. His current INR is 1.61.6. Vital signs are temperature 37.1∘C37.1^{\circ}\text{C} (98.8∘F98.8^{\circ}\text{F}), blood pressure 130/80 mmHg130/80 \text{ mmHg}, and heart rate 88/min88/\text{min}. Physical examination of the right lower extremity reveals a pale, cold leg. Popliteal and dorsalis pedis pulses are absent on Doppler ultrasound. Sensation to light touch is markedly diminished over the dorsum of the foot, and the patient is unable to actively dorsiflex his right toes. Laboratory studies reveal a platelet count of 65,000/mm365,000/\text{mm}^3, a significant decrease from 280,000/mm3280,000/\text{mm}^3 on admission. Which of the following procedural and pharmacological interventions are indicated as the most appropriate next steps in this patient's management? (Select 3)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Immediate discontinuation of the unfractionated heparin infusion; Urgent vascular surgery consultation for surgical embolectomy; Initiation of an intravenous non-heparin anticoagulant such as argatroban

Cevap

The correct interventions are the immediate discontinuation of unfractionated heparin, initiation of an intravenous non-heparin anticoagulant (such as argatroban), and an urgent vascular surgery consultation for surgical embolectomy.
This patient presents with Rutherford Category IIb acute limb ischemia (rest pain, sensory loss, mild motor weakness, absent pulses), an immediately threatened limb requiring emergent surgical revascularization. The etiology is arterial thrombosis secondary to heparin-induced thrombocytopenia (HIT), evidenced by the >50% drop in platelets occurring 7 days after starting unfractionated heparin. Management requires immediately stopping all heparin products, starting a non-heparin direct thrombin inhibitor (e.g., argatroban) to prevent further thrombosis and maintain anticoagulation for his mechanical valve, and consulting vascular surgery for an emergent surgical embolectomy.

Adım Adım Çözüm

1
Evaluate the clinical presentation of the right lower extremity.
The patient exhibits signs of Rutherford Category IIb acute limb ischemia (sensory loss, motor deficit, absent pulses).
Identifying an immediately threatened limb establishes the need for emergent surgical revascularization.
2
Determine the etiology of the arterial thrombosis and thrombocytopenia.
The combination of a >50% platelet drop over 7 days of heparin therapy with new-onset thrombosis strongly indicates Heparin-Induced Thrombocytopenia (HIT).
Accurate etiologic diagnosis alters the standard pharmacological approach to bridging and thrombosis management.
3
Formulate a comprehensive procedural and pharmacological management plan.
Discontinue all heparin, start a direct thrombin inhibitor, and proceed with emergency embolectomy.
This multimodal approach simultaneously arrests the systemic immune-mediated prothrombotic state and salvages the ischemic limb.

Anahtar Kavram

Management of acute limb ischemia in the setting of heparin-induced thrombocytopenia
Soru 1831Soru →

A 28-year-old woman presents to the outpatient clinic to discuss laboratory results obtained during a health screening for a new life insurance policy. She feels well and reports no bone pain, abdominal pain, nausea, polyuria, polydipsia, or mood changes. The patient has no personal history of fractures, peptic ulcer disease, or nephrolithiasis. Family history is notable for her father having a chronically elevated calcium level that "never required treatment or surgery." Vital signs are within normal limits. Physical examination reveals a non-tender neck with no palpable masses or thyromegaly.

Initial laboratory evaluation shows:
Serum calcium: 11.3 mg/dL11.3\text{ mg/dL} (normal: 8.4−10.2 mg/dL8.4-10.2\text{ mg/dL})
Serum albumin: 4.0 g/dL4.0\text{ g/dL}
Serum phosphorus: 2.4 mg/dL2.4\text{ mg/dL} (normal: 2.5−4.5 mg/dL2.5-4.5\text{ mg/dL})
Intact parathyroid hormone: 82 pg/mL82\text{ pg/mL} (normal: 10−65 pg/mL10-65\text{ pg/mL})
25-hydroxyvitamin D: 34 ng/mL34\text{ ng/mL} (normal: 20−50 ng/mL20-50\text{ ng/mL})
Serum creatinine: 0.8 mg/dL0.8\text{ mg/dL}

Which of the following is the most appropriate next step in the diagnostic workup for this patient?

Cevabı ve açıklamayı göster

Cevap: 24-hour urine calcium and creatinine excretion

Cevap

24-hour urine calcium and creatinine excretion
The correct diagnostic sequence for a patient with newly identified PTH-dependent hypercalcemia (elevated calcium with elevated or inappropriately normal PTH) involves definitively establishing the biochemical etiology before pursuing imaging. The primary differential lies between primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH). FHH is a benign, autosomal dominant disorder caused by a mutation in the calcium-sensing receptor (CaSR). A 24-hour urine collection to calculate the calcium-to-creatinine clearance ratio is essential; a ratio <0.01< 0.01 strongly suggests FHH, while a ratio >0.02> 0.02 points toward PHPT. Establishing this diagnosis early is critical because patients with FHH require no treatment and will not benefit from parathyroidectomy.

Adım Adım Çözüm

1
Analyze the initial laboratory data.
The patient has hypercalcemia with an inappropriately elevated intact PTH and normal vitamin D, indicating PTH-dependent hypercalcemia.
Establishing whether hypercalcemia is PTH-dependent or PTH-independent guides the next phase of the diagnostic algorithm.
2
Formulate a differential diagnosis based on the biochemical profile.
The two primary etiologies for PTH-dependent hypercalcemia are primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH).
The patient's family history of untreated hypercalcemia specifically raises the clinical suspicion for FHH.
3
Select the appropriate diagnostic test to differentiate the conditions.
A 24-hour urine collection to calculate the calcium-to-creatinine clearance ratio is required.
A clearance ratio of <0.01< 0.01 indicates FHH (which requires no treatment), while a ratio >0.02> 0.02 confirms PHPT, preventing unnecessary surgical intervention in patients with FHH.

Anahtar Kavram

In patients presenting with PTH-dependent hypercalcemia, the diagnosis of primary hyperparathyroidism must be distinguished from familial hypocalciuric hypercalcemia (FHH) using a 24-hour urine calcium and creatinine excretion test before any imaging or surgical planning occurs.
Soru 1832Soru →

A 6969-year-old man is brought to the emergency department by his daughter due to 33 days of progressive nausea, vomiting, profound weakness, and visual disturbances. He reports that room lights appear to have a "yellowish halo." His medical history includes heart failure with reduced ejection fraction, persistent atrial fibrillation, and chronic kidney disease stage 3b. His daily medications are carvedilol, sacubitril-valsartan, dapagliflozin, and digoxin. Eight days ago, he was prescribed a 77-day course of clarithromycin at an urgent care clinic for an exacerbation of chronic bronchitis.

Vital signs are temperature 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure 105/60105/60 mmHg, heart rate 4646/min, and respiratory rate 1616/min. Physical examination reveals an irregularly irregular, bradycardic rhythm.

Laboratory findings:
Serum sodium: 136136 mEq/L
Serum potassium: 6.36.3 mEq/L
Blood urea nitrogen: 4444 mg/dL
Serum creatinine: 2.22.2 mg/dL (baseline 1.81.8 mg/dL)
Serum digoxin level: 4.84.8 ng/mL (therapeutic range: 0.5−0.90.5-0.9 ng/mL)

An electrocardiogram (ECG) demonstrates atrial fibrillation with a slow ventricular response and frequent, multiform premature ventricular contractions.

Which of the following is the most appropriate initial pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous digoxin-specific antibody fragments

Cevap

The most appropriate initial intervention is intravenous digoxin-specific antibody fragments.
This patient presents with severe digoxin toxicity, likely precipitated by the recent addition of clarithromycin. Clarithromycin is a potent inhibitor of P-glycoprotein, a transport protein responsible for the renal efflux of digoxin; inhibition leads to rapid accumulation of digoxin to toxic levels. Digoxin toxicity manifests with gastrointestinal distress, visual disturbances (yellow halos), and life-threatening arrhythmias. At a cellular level, digoxin directly inhibits the Na+/K+-ATPase pump, preventing potassium from entering the cell and leading to extracellular hyperkalemia. In the setting of digoxin toxicity, a serum potassium level greater than 5.05.0 mEq/L is an indicator of severe poisoning and a strong predictor of mortality. It is an absolute indication for the immediate administration of intravenous digoxin-specific antibody fragments (DigiFab). These fragments bind free digoxin in the serum, pulling the drug off its receptors and rapidly reversing the Na+/K+-ATPase blockade, which corrects both the arrhythmogenic state and the hyperkalemia.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation, medication history, and recent antibiotic use.
The patient has classic signs of digoxin toxicity (nausea, visual halos, bradycardia, premature ventricular contractions) precipitated by clarithromycin, a macrolide antibiotic that inhibits P-glycoprotein and significantly increases serum digoxin levels.
Identifying the precipitating drug interaction and the toxidrome is required to correctly interpret the laboratory findings.
2
Evaluate the laboratory results and ECG findings to determine illness severity.
The patient has severe hyperkalemia (6.36.3 mEq/L), acute-on-chronic kidney injury, a highly elevated digoxin level (4.84.8 ng/mL), and an ECG showing significant rhythm disturbances (bradycardia with multiform PVCs).
Severity markers dictate whether supportive care is sufficient or if an active antidote is immediately required.
3
Select the most appropriate evidence-based pharmacologic intervention.
Severe hyperkalemia (K+ > 5.05.0 mEq/L) in the setting of digoxin toxicity is a primary indication for intravenous digoxin-specific antibody fragments.
Digoxin-specific antibody fragments directly bind free digoxin, reversing the Na+/K+-ATPase blockade, which simultaneously corrects the hyperkalemia and the arrhythmogenic state.

Anahtar Kavram

Digoxin-specific antibody fragments are the first-line pharmacologic intervention for digoxin toxicity complicated by severe hyperkalemia (potassium > 5.0 mEq/L) or life-threatening arrhythmias. Intravenous calcium is contraindicated.
Soru 1833Soru →

A 45-year-old man presents to the outpatient clinic with a three-day history of progressively worsening perianal pain. He reports that the pain is exacerbated by sitting and during bowel movements. His temperature is 37.8°C (100.0°F), blood pressure is 125/80 mmHg, and pulse is 88/min. Physical examination reveals a 3-cm, highly tender, fluctuant, and erythematous mass located adjacent to the left posterior anal verge. There is no overlying tissue necrosis, and the patient has no signs of systemic toxicity or immunocompromise. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Incision and drainage of the mass

Cevap

Incision and drainage of the mass
This patient presents with classic signs of an uncomplicated perianal abscess (a tender, fluctuant, erythematous mass near the anal verge). The standard of care and most appropriate next step is prompt incision and drainage. This simple surgical procedure provides immediate relief of symptoms, evacuates the purulence, and prevents the infection from spreading into deeper perirectal spaces or causing systemic sepsis. While antibiotics may sometimes be added in high-risk patients (e.g., diabetics, immunocompromised), they are never a substitute for adequate surgical drainage.

Adım Adım Çözüm

1
Identify the clinical presentation as an uncomplicated perianal abscess.
The patient has a superficial, fluctuant, and highly tender mass at the anal verge without signs of complex systemic disease.
Accurate clinical diagnosis dictates the urgency and type of intervention required.
2
Determine the definitive treatment for an uncomplicated perianal abscess.
Surgical source control via incision and drainage is required.
Fluid collections and purulence must be mechanically evacuated; medical therapy alone cannot penetrate an un-drained abscess cavity effectively.

Anahtar Kavram

Prompt incision and drainage is the standard of care for uncomplicated perianal abscesses to achieve source control, provide symptom relief, and prevent deeper space infections.
Soru 1834Soru →

An 82-year-old man is being evaluated for hospital discharge following an 8-day admission for an acute left middle cerebral artery ischemic stroke. He is now medically stable but has residual right-sided hemiparesis and moderate oropharyngeal dysphagia. He currently participates in physical and occupational therapy but fatigues after 45 to 60 minutes of total daily activity. The multidisciplinary team is coordinating his transition to a post-acute care setting.

Arrange the following steps of this patient's disposition and care transition process in the correct chronological order to ensure a safe and appropriate handoff.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Evaluate therapy assessments to determine the appropriate post-acute care setting, 2) Submit documentation to secure facility acceptance and authorization, 3) Complete the customized discharge medication reconciliation, and 4) Perform the structured provider-to-provider handoff.
The transition of care is a chronological cascade. Triage based on objective criteria (therapy tolerance) dictates the setting. Securing the setting allows the physician to tailor the medical orders (like dysphagia-appropriate medications) for that specific environment. Finally, the completed plan is handed off to the receiving provider at the time of transfer.

Adım Adım Çözüm

1
Determine the appropriate level of post-acute care.
The patient is triaged to a Skilled Nursing Facility (SNF).
The patient cannot tolerate the minimum 3 hours of intensive daily therapy required for admission to an Inpatient Rehabilitation Facility (IRF).
2
Secure facility placement and insurance authorization.
A bed at the SNF is approved and reserved.
Administrative and logistical clearance is required before medical discharge orders can be meaningfully finalized, as the destination dictates specific transfer protocols.
3
Finalize the discharge medication reconciliation.
Medications are converted to dysphagia-friendly liquid or crushed formulations.
The medical plan must be rigorously optimized for the patient's specific functional deficits and the capabilities of the receiving facility.
4
Execute the provider-to-provider handoff.
Care is officially transferred to the accepting physician.
Safe transitions require clear, real-time communication of the hospital course, pending items, and advance directives immediately prior to the physical transfer.

Anahtar Kavram

Safe disposition and transition of care requires a sequential process: defining the appropriate level of care based on functional capacity (e.g., the 3-hour rule for IRFs), securing placement, tailoring the medication reconciliation to the patient's current deficits, and executing a structured provider handoff.
Soru 1835Soru →

A 72-year-old male patient is currently hospitalized in the medical step-down unit for management of a severe cerebrovascular accident. He requires continuous enteral nutrition via a nasogastric tube due to profound dysphagia. His daily glycemic control is maintained using scheduled subcutaneous NPH insulin every 12 hours and regular insulin every 6 hours. An unexpected complication arises, requiring immediate transfer for an emergent procedure. Consequently, his continuous enteral feeding is abruptly halted. Arrange the following steps for metabolic monitoring and treatment evaluation in the most appropriate chronological sequence to ensure patient safety.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is to first initiate a 10% dextrose infusion, then hold scheduled insulin, monitor blood glucose every 1 to 2 hours, treat any resulting hyperglycemia strictly with correctional insulin, and finally resume the original regimen once feeding is successfully re-established.
The correct sequence prioritizes the immediate physiological threat of hypoglycemia. Because intermediate-acting NPH insulin has already been administered and will continue to act for up to 18 hours, abruptly stopping the patient's continuous carbohydrate source (enteral feeds) will lead to profound hypoglycemia. Therefore, the immediate first step is to replace the lost carbohydrates with an intravenous dextrose infusion matching the previous feeding rate. Once the immediate threat is neutralized, subsequent scheduled insulin doses should be held to prevent adding more insulin to a fasting patient. Close monitoring of blood glucose every 1 to 2 hours is then required to evaluate the effectiveness of the intervention. During this fasting period, any hyperglycemia should be managed solely with short-acting correctional insulin. Finally, the baseline regimen can only be safely restarted after the procedure when the continuous enteral feeding is successfully re-established.

Adım Adım Çözüm

1
Initiate 10% dextrose (D10W) infusion
Replaces the abruptly lost carbohydrate source.
Counteracts the actively circulating, un-retrievable NPH insulin to prevent severe hypoglycemia.
2
Hold upcoming scheduled insulin doses
Prevents the administration of additional unneeded basal or nutritional insulin.
The patient is now fasting; scheduled insulin intended to cover continuous feeds will cause hypoglycemia.
3
Monitor blood glucose every 1 to 2 hours
Provides ongoing, high-frequency safety data.
The balance between active NPH insulin and the intravenous dextrose requires close surveillance to detect dangerous fluctuations.
4
Administer correctional insulin if needed
Treats any incidental hyperglycemia safely.
Correctional (sliding scale) insulin allows for rapid, short-term treatment of high glucose without stacking long-acting agents while feeds are held.
5
Restart baseline insulin regimen
Transitions the patient back to standard glycemic control.
Can only be done safely once the consistent carbohydrate source (enteral feeding) is running at its goal rate.

Anahtar Kavram

Metabolic monitoring and sequence of intervention during the abrupt interruption of continuous enteral nutrition in patients receiving intermediate or long-acting insulin.
Tahmini Süre:2m 0s
Soru 1836Soru →

A 65-year-old man comes to the clinic for a follow-up evaluation. Two weeks ago, he was diagnosed with heart failure with reduced ejection fraction (left ventricular ejection fraction of 35%35\%). At that time, lisinopril was added to his medication regimen, which also includes metoprolol succinate and furosemide. The patient reports feeling well, with significant improvement in his exertional dyspnea. He denies orthopnea, paroxysmal nocturnal dyspnea, or dizziness. Blood pressure is 122/78 mmHg and pulse is 68/min. Physical examination shows no jugular venous distention and clear lungs bilaterally.

Laboratory results two weeks ago (prior to lisinopril initiation):
TestResult
Blood urea nitrogen16 mg/dL
Serum creatinine1.1 mg/dL
Serum potassium4.2 mEq/L
Laboratory results today:
TestResult
Blood urea nitrogen22 mg/dL
Serum creatinine1.4 mg/dL
Serum potassium4.8 mEq/L

Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Continue the current regimen without dose adjustment

Cevap

Continue the current regimen without dose adjustment
The correct approach is to continue the current regimen without dose adjustment. ACE inhibitors (such as lisinopril) block the production of angiotensin II, leading to vasodilation of the efferent arteriole in the kidney. This decreases intraglomerular hydrostatic pressure and effectively lowers the glomerular filtration rate (GFR), which clinically manifests as an initial rise in serum creatinine. Guidelines establish that an increase in serum creatinine of up to 30% from baseline within the first few weeks of starting an ACE inhibitor or angiotensin receptor blocker (ARB) is an expected, physiologic response that stabilizes over time. In this patient, the creatinine increased from 1.11.1 mg/dL to 1.41.4 mg/dL, which is an approximately 27%27\% increase and falls within the acceptable 30%30\% threshold. Furthermore, his serum potassium is 4.84.8 mEq/L, which is safely below the typical intervention threshold of 5.05.0 to 5.55.5 mEq/L. Because the patient is clinically stable and these laboratory changes are within safe limits, lisinopril should be continued to maintain its long-term mortality benefits in heart failure with reduced ejection fraction (HFrEF).

Adım Adım Çözüm

1
Evaluate the patient's clinical status and symptomatic response.
The patient is asymptomatic and euvolemic with improved exertional dyspnea.
To determine if there are signs of decompensated heart failure or adverse drug reactions.
2
Calculate the percentage change in serum creatinine from baseline.
Serum creatinine increased from 1.1 mg/dL to 1.4 mg/dL, which is an increase of approximately 27%.
To quantify the renal impact of initiating the ACE inhibitor.
3
Assess the serum potassium level.
Potassium is 4.8 mEq/L, which is within the normal range.
To ensure the patient has not developed dangerous hyperkalemia, a common side effect of ACE inhibitors.
4
Determine the appropriate management based on pharmacologic guidelines.
Continue the current regimen without dose adjustments.
A creatinine increase of 30% or less is an expected, benign physiologic response to efferent arteriolar vasodilation caused by ACE inhibitors.

Anahtar Kavram

Initiation of ACE inhibitors can cause a benign, physiologic increase in serum creatinine of up to 30% from baseline due to efferent arteriolar vasodilation. If the increase is ≤30% and hyperkalemia is absent, the medication should be continued without dose adjustment.
Soru 1837Soru →

A 78-year-old man is admitted to the hospital with acute decompensated heart failure. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 15% and stage 4 chronic kidney disease. This is his fourth admission for a heart failure exacerbation in the past six months. During this hospitalization, attempts to transition him from intravenous to oral diuretics resulted in symptomatic hypotension, worsening renal function, and severe dyspnea. He is currently maintained on a continuous intravenous milrinone infusion on the telemetry unit, which keeps his breathing comfortable at rest, though he experiences significant dyspnea when attempting to walk to the bathroom. The patient has been evaluated by the advanced heart failure team and is deemed ineligible for a left ventricular assist device (LVAD) or cardiac transplantation due to his advanced age and comorbidities. He is fully alert and oriented. During a family meeting, he clearly states, "I am tired of being in the hospital. I just want to go home and be comfortable. I do not want to be put on a breathing machine or shocked if my heart stops." He lives with his daughter, who is supportive and able to be present at home most of the day. Which of the following is the most appropriate disposition plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home with a referral for home hospice care and continue the continuous intravenous milrinone infusion

Cevap

Discharge home with a referral for home hospice care and continue the continuous intravenous milrinone infusion
The patient has end-stage heart failure, has exhausted advanced treatment options, and has clear goals of care focused on comfort and returning home. He is dependent on milrinone for symptom control, having failed weaning attempts. A common misconception is that patients requiring continuous intravenous infusions cannot be discharged home. However, continuous intravenous inotropes (such as milrinone or dobutamine) can be safely continued at home as palliative therapy under the management of a home hospice agency. This disposition perfectly aligns with his preference to return home, avoid further hospitalizations, and remain comfortable.

Adım Adım Çözüm

1
Assess the patient's clinical status and prognosis.
The patient has end-stage (NYHA Class IV) heart failure, is ineligible for advanced therapies, and is dependent on a continuous milrinone infusion for symptom control.
Establishing the severity of illness and reversibility is necessary to determine the appropriate level of post-acute care.
2
Identify the patient's specific goals of care.
The patient desires a palliative approach, specifically requesting to return home, prioritize comfort, and avoid aggressive resuscitation (DNI/DNR).
Patient autonomy and stated goals dictate the direction of medical management and disposition planning.
3
Evaluate care settings that can safely accommodate the patient's medical needs while honoring his goals.
Standard home health cannot adequately manage actively dying patients on vasoactive drips, while LTACHs and rehab facilities conflict with his desire to go home and focus on comfort.
Matching the clinical requirements with facility capabilities prevents unsafe discharges and goal-discordant care.
4
Select the appropriate disposition.
Home hospice is selected, as hospice agencies can safely manage continuous palliative inotrope infusions (like milrinone) to alleviate dyspnea in the home setting.
Palliative inotropes are a standard, accepted therapy within hospice care for end-stage heart failure.

Anahtar Kavram

Disposition of end-stage heart failure patients to home hospice with the continuation of palliative continuous intravenous inotropes for symptom management.
Soru 1838Soru →

Following a high-speed collision with a concrete barrier, a 51-year-old female driver is extricated from her vehicle and arrives at the trauma resuscitation bay via a medical helicopter. She is fully awake but reports agonizing lower truncal pain.

Her vital signs are as follows:
Blood pressure: 64/34 mmHg
Heart rate: 144/min
Respiratory rate: 26/min
Oxygen saturation: 94% on supplemental oxygen

Physical examination reveals a mechanically unstable pelvic ring with severe crepitus elicited upon gentle bilateral compression of the iliac crests. The patient's abdomen is flat and non-tender. The focused assessment with sonography for trauma (FAST) reveals no pericardial effusion and no free fluid in the dependent abdominal recesses. Two large-bore peripheral intravenous lines are currently being established by the nursing staff.

Which of the following is the single most urgent initial step to stabilize this patient's condition?

Cevabı ve açıklamayı göster

Cevap: Application of a pelvic binder centered over the greater trochanters

Cevap

Application of a pelvic binder centered over the greater trochanters
This patient is in profound hemorrhagic shock due to an unstable pelvic fracture, as evidenced by mechanical instability, severe hypotension, and a negative FAST scan (which rules out significant intraperitoneal bleeding). In pelvic fractures, hemorrhage is most commonly venous (from the presacral plexus) or from fractured cancellous bone. The immediate priority in the resuscitation bay, even before definitive hemorrhage control like angiography or preperitoneal packing, is to reduce pelvic volume. Applying a pelvic binder mechanically stabilizes the fracture fragments, prevents dislodging of early clots, and creates a tamponade effect on venous bleeding. This intervention is rapid, noninvasive, and must be performed immediately.

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and mechanism of injury.
The patient is in profound shock following high-speed blunt trauma.
Identifying life-threatening hemodynamic instability dictates an immediate transition to emergent resuscitation.
2
Localize the primary source of major hemorrhage.
The FAST exam is negative, but the pelvic exam shows gross mechanical instability.
A negative FAST in an unstable blunt trauma patient points to the retroperitoneum (pelvis) or thorax as the source of hidden blood loss.
3
Select the most urgent noninvasive intervention to control the identified hemorrhage source.
Application of a pelvic binder is chosen as the immediate next step.
A pelvic binder rapidly reduces pelvic volume, tamponading venous bleeding and stabilizing fracture fragments.

Anahtar Kavram

In a hemodynamically unstable patient with a pelvic fracture and a negative FAST exam, the most urgent initial stabilization step is the application of a circumferential pelvic binder to mechanically tamponade retroperitoneal bleeding.
Tahmini Süre:1m 30s
Soru 1839Soru →

A 38-year-old man is being treated with isoniazid, rifampin, pyrazinamide, and ethambutol for active pulmonary tuberculosis. Four weeks into his therapy, he presents to the clinic reporting new-onset nausea, right upper quadrant abdominal discomfort, and dark urine. Physical examination reveals mild scleral icterus. Arrange the following steps for the evaluation and longitudinal management of this patient's suspected drug-induced liver injury in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first measure liver transaminases, immediately discontinue the hepatotoxic agents, monitor the enzymes until they safely improve, and finally reintroduce the medications sequentially.
The standard protocol for managing symptomatic hepatotoxicity during tuberculosis treatment involves confirming the injury with laboratory tests, immediately discontinuing the likely offending agents (isoniazid, rifampin, pyrazinamide), monitoring until enzymes normalize to safe levels, and sequentially re-challenging the patient to identify the specific drug responsible.

Adım Adım Çözüm

1
Measure liver transaminases and bilirubin
Confirmation of biochemical liver injury severity
To objectively evaluate the cause of the patient's nausea, abdominal pain, and jaundice.
2
Discontinue offending hepatotoxic drugs
Prevention of further liver necrosis
Isoniazid, rifampin, and pyrazinamide are highly hepatotoxic and must be stopped immediately in the setting of symptomatic transaminitis.
3
Observe and monitor serial laboratory values
Documentation of resolving transaminitis
To ensure the liver has adequately recovered before challenging it with medications again.
4
Perform stepwise reintroduction of medications
Identification of the tolerated therapeutic regimen
To determine the exact offending agent and safely establish a continuation phase regimen.

Anahtar Kavram

Management of anti-tuberculosis drug-induced hepatotoxicity requires immediate cessation of hepatotoxic drugs upon symptomatic elevation of transaminases, followed by serial monitoring and stepwise reintroduction.
Soru 1840Soru →

Following an emergency medical transport, a 6868-year-old male is urgently evaluated in the resuscitation bay for sudden-onset, excruciating retrosternal pain that radiates directly to his thoracic spine. The episode began one hour prior while he was resting. His medical history is notable for medication-noncompliant hypertension and tobacco use disorder. On initial assessment, the patient is overtly pale, diaphoretic, and lethargic. Vital signs reveal a blood pressure of 82/5082/50 mm Hg in the right arm and 60/4060/40 mm Hg in the left arm, a pulse of 118118/min, and a respiratory rate of 2222/min. Auscultation of the precordium demonstrates a new early diastolic decrescendo murmur at the right upper sternal border. An electrocardiogram reveals sinus tachycardia with no ST-segment or T-wave abnormalities. A portable anteroposterior chest radiograph shows widening of the mediastinal silhouette. Which of the following is the most appropriate next step in the diagnostic workup of this patient?

Cevabı ve açıklamayı göster

Cevap: Transesophageal echocardiography

Cevap

Transesophageal echocardiography
Transesophageal echocardiography (TEE) is the diagnostic test of choice for suspected aortic dissection in hemodynamically unstable patients. This patient's tearing back pain, asymmetric blood pressures, new aortic regurgitation murmur, and widened mediastinum strongly suggest an aortic dissection (Stanford type A). His hypotension and lethargy indicate shock (likely due to tamponade, severe aortic regurgitation, or rupture). TEE can be performed rapidly at the bedside without interrupting continuous monitoring and resuscitation, making it vastly superior in this specific context compared to CT angiography, which requires transporting an unstable patient.

Adım Adım Çözüm

1
Analyze the clinical presentation and physical findings.
The patient exhibits classic signs of an acute ascending aortic dissection, including tearing retrosternal pain radiating to the back, an upper extremity pulse/blood pressure differential, a new diastolic murmur of aortic regurgitation, and a widened mediastinum on chest radiograph.
Establishing a high pretest probability for aortic dissection is necessary to guide the diagnostic algorithm.
2
Assess the patient's current hemodynamic status.
The patient has severe hypotension (82/5082/50 mm Hg), tachycardia (118118/min), and lethargy, indicating cardiogenic or obstructive shock (potentially secondary to cardiac tamponade or acute aortic valve incompetence).
Hemodynamic stability is the primary branch point in the algorithm for evaluating suspected aortic dissection.
3
Select the most appropriate, safest diagnostic imaging modality.
Transesophageal echocardiography is selected over computed tomography angiography because it can be rapidly performed at the bedside in the resuscitation bay.
Transporting a hemodynamically unstable patient to the CT scanner is unsafe. Bedside imaging allows for continuous resuscitation and monitoring while still providing high diagnostic sensitivity and specificity.

Anahtar Kavram

In patients with a high clinical suspicion for acute aortic dissection who present with hemodynamic instability, bedside transesophageal echocardiography is the most appropriate next diagnostic step to confirm the diagnosis without risking clinical deterioration during transport.
Tahmini Süre:1m 0s
ÖncekiSayfa 92 / 237Sonraki